Dare Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $8.7M | $7.6M | $4.7M |
| FY2021 | $17.1M | $55.8M | $51.7M |
| FY2022 | $32.7M | $43.8M | $34.7M |
| FY2023 | $26.3M | $21.3M | $10.5M |
| FY2024 | $28.1M | $22.1M | $15.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $8.7M | $7.6M | $4.7M |
| FY2021 | $17.1M | $55.8M | $51.7M |
| FY2022 | $32.7M | $43.8M | $34.7M |
| FY2023 | $26.3M | $21.3M | $10.5M |
| FY2024 | $28.1M | $22.1M | $15.7M |